OXYTROL FOR WOMEN OTC
Generic Name and Formulations:
Oxybutynin 3.9mg/day; transdermal patch.
Merck Consumer Care, Inc.
Indications for OXYTROL FOR WOMEN:
Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
≥18yrs: Apply to clean, dry and smooth area on the abdomen, hips, or buttocks. Use 1 patch for 4 days in a row. Remove patch after 4 days and apply new one. Rotate application sites. Dispose properly with sticky sides together.
<18yrs: not recommended.
Male patients. Pain or burning when urinating. Blood in urine. Unexplained lower back or side pain. Cloudy or foul-smelling urine. Stress incontinence. Urinary or gastric retention. Glaucoma.
Consider other causes of frequent urination (eg, UTI, diabetes, early pregnancy). Unexplained weight loss. Hepatic or renal impairment. Reevaluate if condition worsens or no improvement after 2 weeks. Nursing mothers.
Additive effects with alcohol, other anticholinergic drugs. Caution with antibiotics (eg, erythromycin, clarithromycin) or antifungals (eg, ketoconazole, itraconazole).
Local reactions (eg, itching, rash, redness), sleepiness, dizziness, blurry vision.
Endocrinology Advisor Articles
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Gender-Related Association Between Physical Activity, Psychological Status in T2D
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Choroidal Thickness Changes in Patients With Untreated Diabetes
- Pre-Pregnancy Fitness Lowers Gestational Diabetes Risk